# Vivos Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/vivos-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 26 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-22T04:47:27.193041+00:00 | | Last reviewed | 2026-10-22T04:47:27.193041+00:00 | ## Identity - Legal name: Vivos Therapeutics, Inc. - Display name: Vivos Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-22T04:47:27.193041+00:00 | | Completeness | 0.409 | | Record Quality | 0.831 | | Directors | 6 | | Committees | 7 | | Governance events | 17 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Anja Krammer: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:5 - Leonard J. Sokolow: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:6 - Mark F. Lindsay: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:7 - Matthew Thompson: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Compensation (member); Compensation; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:8 - R. Kirk Huntsman: Director. Status: current. Independent: false. Since: 2016-01-01. claim_id=alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:9 - Ralph E. Green: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:10 ## Committees - Audit (audit). Chair: Leonard J. Sokolow. Members: Leonard J. Sokolow (chair, current); Anja Krammer (member, current); Ralph E. Green (member, current). committee_id=alpha:committee:vivos-therapeutics-inc:audit - Audit · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Leonard J. Sokolow (member, current). committee_id=alpha:committee:vivos-therapeutics-inc:audit-chair-nominating-and-governance - Audit; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Anja Krammer (member, current); Ralph E. Green (member, current). committee_id=alpha:committee:vivos-therapeutics-inc:audit-compensation-nominating-and-governance - Compensation (compensation). Chair: Mark F. Lindsay. Members: Mark F. Lindsay (chair, current); Anja Krammer (member, current); Matthew Thompson (member, current); Ralph E. Green (member, current). committee_id=alpha:committee:vivos-therapeutics-inc:compensation - Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: Mark F. Lindsay (member, current). committee_id=alpha:committee:vivos-therapeutics-inc:compensation-chair - Compensation; Nominating and Governance · Chair (compensation). Chair: NOT_PUBLISHED. Members: Matthew Thompson (member, current). committee_id=alpha:committee:vivos-therapeutics-inc:compensation-nominating-and-governance-chair - Nominating and Governance (nominating_governance). Chair: Matthew Thompson. Members: Matthew Thompson (chair, current); Anja Krammer (member, current); Leonard J. Sokolow (member, current); Ralph E. Green (member, current). committee_id=alpha:committee:vivos-therapeutics-inc:nominating-and-governance ## Executive leadership - Bradford Amman: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:11 - R. Kirk Huntsman: Co-founder, Chairman of the Board, and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:12 ## Governance events - CFO_CHANGED: Bradford Amman executive of Vivos Therapeutics, Inc., effective 2026-04-15. Effective: 2026-04-15. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:lgq9n11m5mh5b - CEO_CHANGED: R. Kirk Huntsman executive of Vivos Therapeutics, Inc., effective 2026-04-15. Effective: 2026-04-15. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:mawsnnhjll9z - DIRECTOR_APPOINTED: Anja Krammer seat on Vivos Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:zyoyzcysfxb8 - DIRECTOR_APPOINTED: Leonard J. Sokolow seat on Vivos Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:1e787811a577pn - DIRECTOR_APPOINTED: Mark F. Lindsay seat on Vivos Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:1tin3wqddboym - DIRECTOR_APPOINTED: Matthew Thompson seat on Vivos Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:9spn0j11a4my5 - DIRECTOR_APPOINTED: Ralph E. Green seat on Vivos Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:gh400k1a6bwmw - COMMITTEE_CREATED: Audit · Chair; Nominating and Governance committee of Vivos Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:18gtnq791eggn - COMMITTEE_MEMBER_ADDED: Leonard J. Sokolow member of Audit · Chair; Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:z0hv2f1trvwk1 - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance committee of Vivos Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:blzlu81tdxbgk - COMMITTEE_MEMBER_ADDED: Anja Krammer member of Audit; Compensation; Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:1gdorxhmoazmn - COMMITTEE_MEMBER_ADDED: Ralph E. Green member of Audit; Compensation; Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:1c6rhppc5acqb - COMMITTEE_CREATED: Compensation · Chair committee of Vivos Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:6rmkwy1hq8r32 - COMMITTEE_MEMBER_ADDED: Mark F. Lindsay member of Compensation · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:21xymf146juur - COMMITTEE_CREATED: Compensation; Nominating and Governance · Chair committee of Vivos Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:1nj5f6hhpyyu1 - COMMITTEE_MEMBER_ADDED: Matthew Thompson member of Compensation; Nominating and Governance · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:pdqev61njw6vm - DIRECTOR_APPOINTED: R. Kirk Huntsman seat on Vivos Therapeutics, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-22T04:47:27.193041+00:00. event_id=alpha:event:transition:1l8z2kpt7b8gd ## Scoped resources - `alpha://company/vivos-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record - `alpha://company/vivos-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=identity - `alpha://company/vivos-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/vivos-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=board - `alpha://company/vivos-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=committees - `alpha://company/vivos-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=leadership - `alpha://company/vivos-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=ownership - `alpha://company/vivos-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=financials - `alpha://company/vivos-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/vivos-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=compensation - `alpha://company/vivos-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=governance - `alpha://company/vivos-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/vivos-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=audit - `alpha://company/vivos-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=legal - `alpha://company/vivos-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=risk - `alpha://company/vivos-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=cyber - `alpha://company/vivos-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/vivos-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=agents - `alpha://company/vivos-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/vivos-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=events - `alpha://company/vivos-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=relationships - `alpha://company/vivos-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=assessments - `alpha://company/vivos-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:leonard-j-sokolow","name":"Leonard J. Sokolow"},"source_id":"board_seats"}` - Claim alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:anja-krammer","name":"Anja Krammer"},"source_id":"board_seats"}` - Claim alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:ralph-e-green","name":"Ralph E. Green"},"source_id":"board_seats"}` - Claim alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:mark-f-lindsay","name":"Mark F. Lindsay"},"source_id":"board_seats"}` - Claim alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:anja-krammer","name":"Anja Krammer"},"source_id":"board_seats"}` - Claim alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:matthew-thompson","name":"Matthew Thompson"},"source_id":"board_seats"}` - Claim alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:ralph-e-green","name":"Ralph E. Green"},"source_id":"board_seats"}` - Claim alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:matthew-thompson","name":"Matthew Thompson"},"source_id":"board_seats"}` - Claim alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:anja-krammer","name":"Anja Krammer"},"source_id":"board_seats"}` - Claim alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:leonard-j-sokolow","name":"Leonard J. Sokolow"},"source_id":"board_seats"}` - Claim alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:ralph-e-green","name":"Ralph E. Green"},"source_id":"board_seats"}` ## Leadership - Anja Krammer: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:5. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:63c28f82382815b2c2a894768e5e83f177b20d4e45fa1bfcb482f3443d68a225. - Leonard J. Sokolow: Director, Audit · Chair; Nominating and Governance. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:63c28f82382815b2c2a894768e5e83f177b20d4e45fa1bfcb482f3443d68a225. - Mark F. Lindsay: Director, Compensation · Chair. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:63c28f82382815b2c2a894768e5e83f177b20d4e45fa1bfcb482f3443d68a225. - Matthew Thompson: Director, Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:8. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:63c28f82382815b2c2a894768e5e83f177b20d4e45fa1bfcb482f3443d68a225. - R. Kirk Huntsman: Director. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:9. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:63c28f82382815b2c2a894768e5e83f177b20d4e45fa1bfcb482f3443d68a225. - Ralph E. Green: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:10. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:63c28f82382815b2c2a894768e5e83f177b20d4e45fa1bfcb482f3443d68a225. - Bradford Amman: Chief Financial Officer. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:11. Valid from: 2026-04-15. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:271875505aed4a86105960f02ae534af4db303423cfbab219f3abee5b05d2d18. - R. Kirk Huntsman: Co-founder, Chairman of the Board, and Chief Executive Officer. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:leadership_role:12. Valid from: 2026-04-15. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da686b4a30efb3d56bdf77afc6b9bdd54a05abb993503d3be5a92fcfba836327. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Leonard J. Sokolow; Members Leonard J. Sokolow (Chair); Anja Krammer; Ralph E. Green. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. - Compensation: Chair Mark F. Lindsay; Members Mark F. Lindsay (Chair); Anja Krammer; Matthew Thompson; Ralph E. Green. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. - Nominating and Governance: Chair Matthew Thompson; Members Matthew Thompson (Chair); Anja Krammer; Leonard J. Sokolow; Ralph E. Green. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Vivos Therapeutics, Inc.. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1f18ba25763d451ba9d0eaa343ad97f67365ef7fc233377a9a959a0b27014e5b. ## Entity Status - Public listing published. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1f18ba25763d451ba9d0eaa343ad97f67365ef7fc233377a9a959a0b27014e5b. ## Published Fact - US. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1f18ba25763d451ba9d0eaa343ad97f67365ef7fc233377a9a959a0b27014e5b. ## Committee Appointment - Leonard J. Sokolow: chair, Audit. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. - Anja Krammer: member, Audit. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. - Ralph E. Green: member, Audit. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. - Mark F. Lindsay: chair, Compensation. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. - Anja Krammer: member, Compensation. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. - Matthew Thompson: member, Compensation. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. - Ralph E. Green: member, Compensation. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. - Matthew Thompson: chair, Nominating and Governance. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. - Anja Krammer: member, Nominating and Governance. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. - Leonard J. Sokolow: member, Nominating and Governance. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. - Ralph E. Green: member, Nominating and Governance. Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0. ## Security Listing - VVOS (NASDAQ). Claim: alpha:claim:company:3034f99a-84c8-4cdb-b9ff-cdebba5a8921:security_listing:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1f18ba25763d451ba9d0eaa343ad97f67365ef7fc233377a9a959a0b27014e5b. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:1f18ba25763d451ba9d0eaa343ad97f67365ef7fc233377a9a959a0b27014e5b: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/vivos-therapeutics-inc). - alpha:projection-evidence:document:63c28f82382815b2c2a894768e5e83f177b20d4e45fa1bfcb482f3443d68a225: [Vivos Therapeutics, Inc. DEF 14A 2025-09-29](https://www.sec.gov/Archives/edgar/data/1716166/000149315225015837/formdef14a.htm). - alpha:projection-evidence:document:271875505aed4a86105960f02ae534af4db303423cfbab219f3abee5b05d2d18: [VVOS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1716166/000149315226016854/form10-k.htm). - alpha:projection-evidence:document:da686b4a30efb3d56bdf77afc6b9bdd54a05abb993503d3be5a92fcfba836327: [VVOS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1716166/000149315226016854/form10-k.htm). - alpha:projection-evidence:f70c5cdf3f630ee1b811217525575f6d477fa5c265f7594affb120a0a7cebdc0: [Audit](https://www.sec.gov/Archives/edgar/data/1716166/000149315225015837/formdef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/vivos-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/vivos-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/vivos-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/vivos-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-23T01:14:07.045544+00:00; recorded 2026-10-23T01:14:07.045544+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.